Kelly Scott, PA-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Texas Tech University Health Sciences Center, 3600 N Garfield, Midland, TX 79705 Phone: 432-620-1120 |
Dr. Manmeet Mangat, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 400 N Garfield St, Suite 100, Midland, TX 79701 Phone: 432-685-1559 Fax: 435-682-6973 |
Jeffrey Hunter Atkins, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4507 Santa Rosa Dr, Midland, TX 79707 Phone: 432-683-8516 |
Dr. Venkatasubbaraya Chowdary Achanta, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 400 Rosalind Redfern Grover Pkwy, Midland, TX 79701 Phone: 432-221-1111 |
Daniel Mekonnen Gellan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 400 Rosalind Redfern Grover Pkwy, Midland, TX 79701 Phone: 432-221-1111 |
News Archive
A new automated sample preparation system based on Tecan's Freedom EVO- 200 liquid handling platform has been developed for proteomic biomarker discovery and validation in collaboration with the Translational Genomics Research Institute (TGen) and the Biodesign Institute at Arizona State University.
This rare genetic condition can theoretically affect patients at any age but symptoms are more often observed in childhood and even uncommonly during the first days of life.
For the fourth consecutive year, Abbott (NYSE: ABT) has been named one of the "50 Best Places to Launch a Career" by BusinessWeek magazine. The list highlights companies that excel at offering a superior workplace for entry-level employees. This year, Abbott moved up to No. 13, and was once again the top-ranked health care company on the list. Abbott has been included on the list every year since BusinessWeek initiated the list in 2006.
Unilife Medical Solutions Limited (Unilife Australia or the Company) (ASX: UNI) (PINKSHEETS: UNIFF) today announced that it entered into a Merger Implementation Agreement with Unilife Corporation (Unilife USA), a wholly owned subsidiary of Unilife Australia. The purpose of the Merger Implementation Agreement is to facilitate the proposed redomiciliation of the Unilife group to the United States of America (Proposed Transaction).
In a retrospective study, Saint Louis University researchers have found that patients with melanoma brain metastases can be treated with large doses of interleukin-2 (HD IL-2), a therapy that triggers the body's own immune system to destroy the cancer cells.
› Verified 5 days ago